Xtant Medical Holdings (XMS) Financial Statements
Xtant Medical Holdings Financial Overview
Xtant Medical Holdings's market cap is currently $35.08M. The company's EPS TTM is $-0.06; its P/E ratio is -3.40; Xtant Medical Holdings is estimated to report earnings on November 6, 2026, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 133.93M | $ 117.27M | $ 91.30M | $ 57.97M | $ 55.26M |
| Gross Profit | $ 84.27M | $ 68.22M | $ 55.47M | $ 32.14M | $ 32.49M |
| Operating Income | $ 7.28M | $ -12.07M | $ -10.16M | $ -6.75M | $ -3.85M |
| EBITDA | $ 15.89M | $ -7.88M | $ 5.08M | $ -5.43M | $ -2.52M |
| Net Income | $ 4.97M | $ -16.45M | $ 660.00K | $ -8.48M | $ -4.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.05M | $ 6.20M | $ 5.71M | $ 20.30M | $ 18.24M |
| Total Assets | $ 94.14M | $ 93.84M | $ 92.61M | $ 60.23M | $ 54.69M |
| Total Debt | $ 28.72M | $ 35.14M | $ 23.56M | $ 17.07M | $ 16.84M |
| Net Debt | $ 11.66M | $ 28.94M | $ 17.84M | $ -3.23M | $ -1.40M |
| Total Liabilities | $ 43.19M | $ 50.87M | $ 41.26M | $ 26.06M | $ 23.81M |
| Stockholders' Equity | $ 50.95M | $ 42.96M | $ 51.35M | $ 34.17M | $ 30.88M |
| Cash Flow | |||||
| Free Cash Flow | $ 10.16M | $ -16.01M | $ -10.97M | $ -7.11M | $ -1.68M |
| Operating Cash Flow | $ 12.55M | $ -11.90M | $ -9.52M | $ -5.34M | $ 439.00K |
| Investing Cash Flow | $ 7.90M | $ -3.73M | $ -24.78M | $ -1.56M | $ -1.89M |
| Financing Cash Flow | $ -9.57M | $ 16.07M | $ 19.69M | $ 9.02M | $ 17.50M |
Currency in USD